Hiding or snatching epitopes?

Antibodies forming a posh with antigen in vivo can dramatically change the antibody response to this antigen. In some conditions, the response shall be a 100-fold stronger than in animals immunized with antigen alone, and in different conditions, the response shall be utterly suppressed. IgG is understood to suppress the antibody response, for instance to erythrocytes, and that is used clinically in Rhesus prophylaxis.

 

Gentaurprices
Gentaurprices

anti- Kallikrein 11 antibody

FNab04457 100µg
EUR 606.3
Description: Antibody raised against Kallikrein 11

anti- Kallikrein 2 antibody

FNab04458 100µg
EUR 658.5
Description: Antibody raised against Kallikrein 2

anti- Kallikrein 5 antibody

FNab04459 100µg
EUR 702
Description: Antibody raised against Kallikrein 5

anti- Kallikrein 8 antibody

FNab04460 100µg
EUR 606.3
Description: Antibody raised against Kallikrein 8

Kallikrein

KB0545 250mg
EUR 91.32

Kallikrein-1

20-abx073980
  • EUR 1930.80
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 10 ug
  • 2 µg

Kallikrein antibody

70R-14246 100 ug
EUR 386.4
Description: Affinity purified Rabbit polyclonal Kallikrein antibody

Kallikrein-11 Antibody

R30714 100 ug
EUR 356.15
Description: Kallikrein-11, also called PRSS20 or TLSP, is a protein that in humans is encoded by the KLK11 gene. It is a member of the kallikrein subfamily of serine proteases, which are involved in a variety of enzymatic processes. The gene contains 6 exons, the first of which is noncoding. KLK11 shares 48% amino acid sequence identity with mouse neuropsin, 43% identity with both human trypsin-1 and human kallikrein, and 38% identity with the mouse nerve growth factor gamma subunit. Alternate splicing of the KLK11 gene results in two transcript variants encoding two different isoforms which are differentially expressed. Western blot analysis of recombinant KLK11 suggested that the protein is secreted and posttranslationally processed.

Kallikrein-3 Antibody

20-abx137265
  • EUR 844.80
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 20 ug
  • 5 ug

Kallikrein-1 Antibody

R30707 100 ug
EUR 356.15
Description: Kallikrein-1, also called KLK1 and KLKR, is a protein that in humans is encoded by the KLK1 gene. KLK1 is a member of the peptidase S1 family. It is a serine protease that generates Lys-bradykinin by specific proteolysis of kininogen-1. The gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19 and its exact cytogenetic location is 19q13.33. Mice lacking the protein are unable to generate significant levels of kinins in most tissues and develop cardiovascular abnormalities early in adulthood despite normal blood pressure. The protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen.

Kallikrein-2 Antibody

R30708 100 ug
EUR 356.15
Description: Kallikrein-2, also called KLK2, is a protein that in humans is encoded by the KLK2 gene, and is particularly associated with prostatic tissue. It is a member of glandular kallikrein gene family that comprises 25 to 30 highly homologous genes that encode specific proteases involved in the processing of biologically active peptides. An alternative KLK2 transcript, call KLK2-linked molecule (KLM), arises from the use of an alternate donor site within intron one. KLM shares only the N-terminal 15-amino acid signal peptide with the original KLK2 protein; the mature proteins display no similarity.

Kallikrein-5 Antibody

R30713 100 ug
EUR 356.15
Description: Kallikrein-5, formerly known as Stratum corneum tryptic enzyme (SCTE) or KLKL2, is a serine protease expressed in the epidermis. The gene is one of the fifteen kallikrein subfamily members which is located on 19q13.41. KLK5 has been suggested to regulate cell shedding in conjunction with KLK7 and KLK14, given its ability to degrade proteins which form the extracellular component of cell junctions in the stratum corneum. The KLK5 gene contains 5 coding exons spanning 9.3. KLK5 expression is upregulated in a breast cancer cell line in the presence of estrogens and progestins and is associated with more aggressive forms of epithelial ovarian carcinoma.

Kallikrein-1 Antibody

R30716 100 ug
EUR 356.15
Description: Kallikrein-1, also called KLKR, is a protein that in humans is encoded by the KLK1 gene. It is a member of the peptidase S1 family. KLK1 is a serine protease that generates Lys-bradykinin by specific proteolysis of kininogen-1. The gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19 and its exact cytogenetic location is 19q13.33. The KLK1 gene contains 5 coding exons. And KLK1 is the most centromeric gene in the cluster. Mice lacking tissue kallikrein are unable to generate significant levels of kinins in most tissues and develop cardiovascular abnormalities early in adulthood despite normal blood pressure. The protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen.

Kallikrein 11

MO15030 100 ug
EUR 381.6

Kallikrein 11

GT15082 100 ug
EUR 600

Kallikrein 10

GT15096 100 ug
EUR 631.2

Kallikrein 15 Antibody

39370-100ul 100ul
EUR 468

Kallikrein 14 Antibody

39246-100ul 100ul
EUR 468

Kallikrein 15 Antibody

abx037703-100ug 100 ug
EUR 469.2

Kallikrein 9 Antibody

20-abx100986
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Kallikrein 11 antibody

70R-50844 100 ul
EUR 292.8
Description: Purified Polyclonal Kallikrein 11 antibody

Kallikrein 8 antibody

70R-50856 100 ul
EUR 292.8
Description: Purified Polyclonal Kallikrein 8 antibody

Kallikrein 3 antibody

70R-49385 100 ul
EUR 292.8
Description: Purified Polyclonal Kallikrein 3 antibody

Kallikrein 7 Antibody

DF7384 200ul
EUR 420

Kallikrein 4 Antibody

DF14058 100ul
EUR 420

Kallikrein 9 Antibody

DF13306 100ul
EUR 420

Kallikrein 6 Antibody

R34403-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Kallikrein related-peptidase 6, Klk6, kallikrein 7, Klk7

Kallikrein 1 Antibody

R30798 100 ug
EUR 356.15
Description: KLK1(KALLIKREIN 1), also called KLKR, is a protein that in humans is encoded by the KLK1 gene. KLK1 is a member of the peptidase S1 family. KLK1 is a serine protease that generates Lys-bradykinin by specific proteolysis of kininogen-1. The KLK1 gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19 and its exact cytogenetic location is 19q13.33. The KLK1 gene contains 5 coding exons. And KLK1 is the most centromeric gene in the cluster. Mice lacking tissue kallikrein are unable to generate significant levels of kinins in most tissues and develop cardiovascular abnormalities early in adulthood despite normal blood pressure. The protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen.

Kallikrein 6 Antibody

R30860 100 ug
EUR 356.15
Description: Kallikrein-related peptidase 6 is a protein that in humans is encoded by the KLK6 gene. This gene is one of the fifteen subfamily members located in a cluster on chromosome 19. The encoded enzyme is regulated by steroid hormones. Northern blot analysis revealed that the PRSS9 mRNA was expressed in several primary tumors and cell lines from mammary, prostate, and ovarian cancers, but was not detected in any metastases of these cancers. The KLK6 gene is mapped on 19q13.41. In tissue culture, the enzyme has been found to generate amyloidogenic fragments from the amyloid precursor protein, suggesting a potential for involvement in Alzheimers disease. Upon cellular stress, neurosin was released from mitochondria to the cytosol, which resulted in the increase of degraded alpha-synuclein species. Neurosin may play a significant role in physiologic alpha-synuclein degradation and also in the pathogenesis of synucleinopathies.

Kallikrein 9 Antibody

R30918 100 ug
EUR 356.15
Description: Kallikrein-related peptidase 9, also known as KLK9 or KLK-L3, belongs to the kallikrein subgroup of serine proteases, which have diverse physiologic functions in many tissues. The KLK9 gene contains 5 coding exons and is mapped to 19q13.41. The gene is regulated by steroid hormones in a human breast cancer cell line. Yousef et al.(2001) performed a quantitative analysis of KLK9 expression in ovarian cancer. The results indicated that KLK9 is under steroid hormone regulation in ovarian and breast cancer cell lines. KLK9 is a potential independent favorable prognostic marker for early-stage, low-grade, optimally debulked ovarian cancer patients.

Kallikrein 10 Antibody

R30919 100 ug
EUR 356.15
Description: Kallikrein-related peptidase 10, also known as KLK10, PRSSL1 or NES1, belongs to the kallikrein subfamily of serine proteases, which are involved in a variety of enzymatic processes. Its encoded protein is secreted and may play a role in suppression of tumorigenesis in breast and prostate cancers. KLK10 contains 12 conserved cysteines in its protease domain that are expected to form 6 disulfide bonds, as in other serine proteases. RT-PCR detected variable levels of KLK10 expression in nearly all of the 35 adult and fetal tissues examined. The gene contains 6 exons, the first of which is noncoding. By fluorescence in situ hybridization, Polikoff et al.(1997) mapped the gene to 19q13.3. By genomic sequence analysis,Gan et al.(2000) mapped the gene within the KLK gene cluster on chromosome 19q13. This cluster includes 13 KLK genes and 5 pseudogenes.

Kallikrein 1 Antibody

R31148 100 ug
EUR 356.15
Description: Kallikrein 1, also called KLKR, is a protein that in humans is encoded by the KLK1 gene. It is a member of the peptidase S1 family, a serine protease that generates Lys-bradykinin by specific proteolysis of kininogen-1. The gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19 and its exact cytogenetic location is 19q13.33. The gene contains 5 coding exons. KLK1 is the most centromeric gene in the cluster. Mice lacking tissue kallikrein are unable to generate significant levels of kinins in most tissues and develop cardiovascular abnormalities early in adulthood despite normal blood pressure. The protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen.

Kallikrein 4 Antibody

R31673 100 ug
EUR 356.15
Description: Kallikrein 4, also known as PSTS or EMSP1, is a protein which in humans is encoded by the KLK4 gene. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. KLKs are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. In particular, they may serve as biomarkers for both prostate cancer and breast cancer. It has been found that Kallikrein 4 is a proliferative factor with effects on gene expression and it may have a role in prostate cancer development and progression.

Kallikrein protein

30R-2456 50 ug
EUR 374.4
Description: Purified native Human Kallikrein protein

Kallikrein-1 Antibody / KLK1

RQ4114 100 ug
EUR 356.15
Description: KLK1 (KALLIKREIN 1), also called KLKR, is a protein that in humans is encoded by the KLK1 gene. KLK1 is a member of the peptidase S1 family. KLK1 is a serine protease that generates Lys-bradykinin by specific proteolysis of kininogen-1. The KLK1 gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19 and its exact cytogenetic location is 19q13.33. The KLK1 gene contains 5 coding exons. And KLK1 is the most centromeric gene in the cluster. Mice lacking tissue kallikrein are unable to generate significant levels of kinins in most tissues and develop cardiovascular abnormalities early in adulthood despite normal blood pressure. The protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen.

Kallikrein-2 Antibody / KLK2

RQ4132 100 ug
EUR 356.15
Description: KLK2 (KALLIKREIN 2), also called GLANDULAR or PROSTATIC, is a protein that in humans is encoded by the KLK2 gene, and is particularly associated with prostatic tissue. The KLK2 is a member of glandular kallikrein gene family that comprises 25 to 30 highly homologous genes that encode specific proteases involved in the processing of biologically active peptides. The KLK2 gene is mapped to 19q13.33.And the KLK2 gene contains 5 exons. An alternative KLK2 transcript, which they call KLK2-linked molecule (KLM), that arises from the use of an alternate donor site within intron 1.KLM shares only the N-terminal 15-amino acid signal peptide with the original KLK2 protein; the mature proteins display no similarity.

Human Kallikrein Antibody

20353-05011 150 ug
EUR 260.4

Kallikrein-3 Enzyme

20-abx073939
  • EUR 1779.60
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 10 ug
  • 2 µg

Rabbit Anti-Human Plasma Kallikrein IgG

KAL11-A 100 ul
EUR 489.6

Kallikrein Inhibitor

5-01416 4 x 5mg Ask for price

Kallikrein 6 (KLK6) Antibody

20-abx318637
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Kallikrein 6 (KLK6) Antibody

20-abx210240
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Kallikrein 8 (KLK8) Antibody

20-abx210241
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Kallikrein 1 (KLK1) Antibody

20-abx225263
  • EUR 444.00
  • EUR 727.20
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 50 ul

Kallikrein 1 (KLK1) Antibody

abx234456-100ug 100 ug
EUR 661.2

The mechanism behind IgG-mediated immune suppression remains to be not understood. Right here, we are going to overview research carried out in experimental animal fashions and talk about the varied hypotheses put ahead to elucidate the profound suppressive impact of IgG. We conclude that an unique position for detrimental regulation of B cells by means of FcγRIIB, elevated clearance of erythrocytes from the circulation or complement-mediated lysis is unlikely.

Epitope masking, the place IgG hides the epitope from B cells, or trogocytosis, the place IgG removes the epitope from the erythrocyte, is appropriate with many observations. These two mechanisms usually are not mutually unique. Furthermore, it can’t be dominated out that clearance, together with different mechanisms, performs a job.

Antibody-mediated rejection with and with out donor-specific anti-human leucocyte antigen antibodies: efficiency of the peripheral blood 8-gene expression Assay

Background: Just lately a peripheral blood 8-gene expression assay was developed for non-invasive detection of antibody-mediated rejection (ABMR) after kidney transplantation. Its worth has not but been evaluated intimately in medical eventualities with totally different baseline illness likelihood [human leucocyte antigen donor-specific antibodies (HLA-DSA)-positive versus HLA-DSA-negative cases at the time of stable graft function versus graft dysfunction].
Strategies: Right here we investigated the diagnostic accuracy of the 8-gene expression assay for histology of ABMR (ABMRh) with or with out HLA-DSA in a cross-sectional cohort examine of 387 blood samples with a concomitant graft biopsy.

Cystatin C Antibody / Cystatin 3

RQ4885 100 ug
EUR 356.15
Description: Cystatin C or cystatin 3, a protein encoded by the CST3 gene, is mainly used as a biomarker of kidney function. Recently, it has been studied for its role in predicting new-onset or deteriorating cardiovascular disease. It also seems to play a role in brain disorders involving amyloid, such as Alzheimer's disease. In humans, all cells with a nucleus (cell core containing the DNA) produce cystatin C as a chain of 120 amino acids. It is found in virtually all tissues and body fluids. It is a potent inhibitor of lysosomal proteinases (enzymes from a special subunit of the cell that break down proteins) and probably one of the most important extracellular inhibitors of cysteine proteases (it prevents the breakdown of proteins outside the cell by a specific type of protein degrading enzymes). Cystatin C belongs to the type 2 cystatin gene family.

anti- Cystatin A antibody

FNab02179 100µg
EUR 606.3
Description: Antibody raised against Cystatin A

anti- Cystatin B antibody

FNab02180 100µg
EUR 606.3
Description: Antibody raised against Cystatin B

anti- Cystatin C antibody

FNab02181 100µg
EUR 606.3
Description: Antibody raised against Cystatin C

anti- Cystatin F antibody

FNab02182 100µg
EUR 658.5
Description: Antibody raised against Cystatin F

Bovine Cystatin (Cystatin) ELISA Kit

YLA0368BO-48T 48T
EUR 502.5

Bovine Cystatin (Cystatin) ELISA Kit

YLA0368BO-96T 96T
EUR 618.75

Anti-CST1/Cystatin Sn Antibody

A30630 100ul
EUR 476.4
Description: Rabbit Polyclonal CST1/Cystatin Sn Antibody. Validated in IF, IHC and tested in Human.

Anti-CST2/Cystatin Sa Antibody

A08736 100ul
EUR 476.4
Description: Rabbit Polyclonal CST2/Cystatin Sa Antibody. Validated in IHC and tested in Human.

Anti-CST1/Cystatin Sn Antibody

A05560 100ul
EUR 476.4
Description: Rabbit Polyclonal CST1/Cystatin Sn Antibody. Validated in IF, IHC and tested in Human.

Anti-CST8/Cystatin 8 Antibody

A11538-1 100ul
EUR 476.4
Description: Rabbit Polyclonal CST8/Cystatin 8 Antibody. Validated in IHC and tested in Human, Mouse.

Anti-CST3 / cystatin C antibody

STJ71888 100 µg
EUR 430.8

Anti-CST11/Cystatin 11 Antibody

A14842 100ul
EUR 476.4
Description: Rabbit Polyclonal CST11/Cystatin 11 Antibody. Validated in WB and tested in Human.

anti-Human Cystatin C Antibody

GCYS-80A 1 x 96 well plate
EUR 553.2

Cystatin C antibody

70-1078 1 mg
EUR 289.2
Description: Purified rabbit polyclonal Cystatin C antibody

Cystatin C Antibody

48015-100ul 100ul
EUR 399.6

Cystatin C Antibody

48015-50ul 50ul
EUR 286.8

Cystatin C Antibody

49285-100ul 100ul
EUR 399.6

Cystatin C Antibody

49285-50ul 50ul
EUR 286.8

Cystatin C antibody

70R-16632 50 ul
EUR 522
Description: Rabbit polyclonal Cystatin C antibody

Cystatin B antibody

70R-14193 100 ug
EUR 386.4
Description: Affinity purified Rabbit polyclonal Cystatin B antibody

Cystatin B antibody

70R-15152 100 ug
EUR 392.4
Description: Rabbit polyclonal Cystatin B antibody

Cystatin C antibody

70R-15209 100 ug
EUR 392.4
Description: Rabbit polyclonal Cystatin C antibody

Cystatin B antibody

70R-2374 50 ug
EUR 560.4
Description: Rabbit polyclonal Cystatin B antibody

Cystatin S antibody

70R-1571 100 ug
EUR 452.4
Description: Rabbit polyclonal Cystatin S antibody raised against the N terminal of CST4

Cystatin C antibody

10-1554 100 ug
EUR 470.4
Description: Mouse monoclonal Cystatin C antibody

Cystatin C antibody

10-1563 1 mg
EUR 312
Description: Mouse monoclonal Cystatin C antibody  

Cystatin C antibody

10-2277 100 ug
EUR 489.6
Description: Recombinant Fab monoclonal Cystatin C antibody

Cystatin C antibody

10-2278 100 ug
EUR 489.6
Description: Recombinant Fab monoclonal Cystatin C antibody

Cystatin A antibody

10R-8038 100 ug
EUR 564
Description: Mouse monoclonal Cystatin A antibody

Cystatin B antibody

10R-8039 100 ug
EUR 564
Description: Mouse monoclonal Cystatin B antibody

Cystatin C antibody

20-1716 10 ml
EUR 159.6
Description: Human Cystatin C antiserum raised in Goat

Cystatin C antibody

20-B9123G000-S0 10 ml
EUR 165.6
Description: Goat polyclonal Human Cystatin C antibody

Cystatin C antibody

20-B9123GD00-D0 5 mg
EUR 230.4
Description: Goat polyclonal Cystatin C antibody

Cystatin C antibody

20-B9123R000-R0 10 ml
EUR 192
Description: Rabbit polyclonal Cystatin C antibody

Cystatin 8 antibody

70R-3907 50 ug
EUR 560.4
Description: Rabbit polyclonal Cystatin 8 antibody

Cystatin B antibody

70R-49608 100 ul
EUR 292.8
Description: Purified Polyclonal Cystatin B antibody

Cystatin B antibody

70R-2262 50 ug
EUR 560.4
Description: Rabbit polyclonal Cystatin B antibody

Cystatin C antibody

70R-13912 100 ug
EUR 418.8
Description: Affinity purified Goat polyclonal Cystatin C antibody

Cystatin 9 antibody

70R-6727 50 ug
EUR 560.4
Description: Rabbit polyclonal Cystatin 9 antibody

Cystatin C antibody

70R-7575 1 mg
EUR 471.6
Description: Affinity purified Goat polyclonal Cystatin C antibody

Cystatin C antibody

10-7884 500 ug
EUR 807.6
Description: Mouse monoclonal Cystatin C antibody

Cystatin C antibody

10-7885 500 ug
EUR 807.6
Description: Mouse monoclonal Cystatin C antibody

Cystatin C antibody

10-7886 500 ug
EUR 807.6
Description: Mouse monoclonal Cystatin C antibody

Cystatin C antibody

10-7887 500 ug
EUR 807.6
Description: Mouse monoclonal Cystatin C antibody

Cystatin 9L Antibody

20-abx121584
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Cystatin 3 Antibody

abx431194-200ul 200 ul
EUR 460.8

Cystatin C Antibody

DF6457 200ul
EUR 420

Cystatin A Antibody

DF7458 200ul
EUR 420

Cystatin 8 Antibody

R33572-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: CST8

Cystatin 3 Antibody

R34143-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Cystatin C; Cst3

Cystatin F Antibody

R35176-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Cystatin 7, CST7, CMAP

Cystatin 8 Antibody

R36084-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: CST8

Cystatin C Antibody

R36096-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: CST3, ARMD11; CST3

Cystatin A Antibody

R31217 100 ug
EUR 356.15
Description: Cystatin A, also called Stefin A, is a protein that in humans is encoded by the CSTA gene. Cystatin A is a cysteine proteinase inhibitor that belongs to family 1 of the cystatin superfamily. This gene was assigned to human chromosome 3q21.1. This is an intracellular thiol proteinase inhibitor. The protein plays an important role in desmosome-mediated cell-cell adhesion in the lower levels of the epidermis and has been proposed as prognostic and diagnostic tools for cancer.

Cystatin 9L1 Antibody

20-abx121073
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Anti-Rat Cystatin C Monoclonal Antibody

A1023-100 each
EUR 444

Cystatin E / M Antibody

20-abx121468
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Cystatin B antibody (HRP)

60R-1293 100 ug
EUR 392.4
Description: Rabbit polyclonal Cystatin B antibody (HRP)

Cystatin C antibody (HRP)

60R-1466 100 ug
EUR 392.4
Description: Rabbit polyclonal Cystatin C antibody (HRP)

Cystatin C/CST3

E21-S25 10ug
EUR 411.6

Cystatin B antibody (FITC)

60R-1294 100 ug
EUR 392.4
Description: Rabbit polyclonal Cystatin B antibody (FITC)

Cystatin C antibody (FITC)

60R-1467 100 ug
EUR 392.4
Description: Rabbit polyclonal Cystatin C antibody (FITC)

Cystatin A (CSTA) Antibody

abx232179-100ug 100 ug
EUR 577.2

Cystatin B (CSTB) Antibody

abx232180-100ug 100 ug
EUR 577.2

Cystatin C (CST3) Antibody

abx232181-100ug 100 ug
EUR 577.2

Cystatin 4 (CST4) Antibody

20-abx213436
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Cystatin B (CSTB) Antibody

20-abx211830
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Cystatin A (CSTA) Antibody

20-abx211984
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Cystatin SN (CST1) Antibody

abx232032-100ug 100 ug
EUR 577.2

Cystatin M (CST6) Antibody

abx232034-100ug 100 ug
EUR 577.2

Cystatin 8 (CST8) Antibody

abx232035-100ug 100 ug
EUR 577.2

Cystatin 7 (CST7) Antibody

20-abx219392
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

Cystatin B (CSTB) Antibody

20-abx109694
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cystatin C (CST3) Antibody

20-abx109695
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
Outcomes: In sufferers with HLA-DSA (n = 64), the 8-gene expression assay discriminated DSA-positive ABMRh (DSAposABMRh) instances (n = 16) with good diagnostic efficiency . Additionally, in HLA-DSA-negative samples (n = 323), a clinically related diagnostic efficiency for DSAnegABMRh instances was discovered (n = 30) with an AUROC of 75.8% (95% CI 67.4-84.4). The 8-gene assay didn’t discriminate DSAposABMRh instances from DSAnegABMRh instances. There was a internet profit for medical decision-making when including the 8-gene expression assay to a medical mannequin consisting of estimated glomerular filtration price, proteinuria, HLA-DSA and age.
Conclusion: The 8-gene expression assay exhibits nice potential for implementation within the medical follow-up of high-risk HLA-DSA-positive sufferers and medical relevance in HLA-DSA-negative instances.